NEWS & EVENTS

News

events

24 May 2022

Da Volterra will be attending BIO International Convention on June 13-16, 2022 in San Diego

The BIO International Convention is the world’s largest leading biotech convention. Currently there are over 3,000+ international and domestic companies…

events

23 May 2022

Da Volterra to attend ASCO Annual Meeting on June 3-7, 2022 in Chicago

Founded in 1964, the American Society of Clinical Oncology is the world’s leading professional organization for physicians and oncology professionals…

news

28 April 2022

Da Volterra Announces Positive Preclinical Results in Immuno-Oncology with DAV132, a Revolutionary Gut Protector

• DAV132 was demonstrated to prevent antibiotic-induced loss of responsiveness to PD-1 blockade cancer therapy in a well-established animal model…

news

10 January 2022

Da Volterra Announces the Publication of Positive Results from the SHIELD Phase 2 Clinical Trial Evaluating DAV132 in Patients in the Journal of Antimicrobial Chemotherapy

• DAV132 Phase 2 results are published in the Journal of Antimicrobial Chemotherapy • DAV132 is well tolerated in patients…

news

17 December 2021

Da Volterra Appoints Khoso Baluch and Nabil Abadir to its Board of Directors

• Two senior pharma executives with a long-standing international experience and know-how in the pharmaceutical and biotechnology industry join…

events

06 December 2021

Da Volterra will attend the 63rd ASH Annual Meeting and Exposition on December 11-14, 2021

The American Society of Hematology (ASH) is the world’s largest professional society concerned with the causes and treatments of blood…

news

16 November 2021

Latest Update of Meta-Analysis Evaluating the Impact of Antibiotic Use on Clinical Outcomes and Treatment Response of Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: Patient Survival and Treatment Response Reduced

Da Volterra is proud to present new results published at the Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting…

events

04 November 2021

Florence Séjourné speaker at the 9th Annual Int’l C. diff. Conference & Health Expo on Nov 4 @ 16h40 CET

The 9th Annual International C. diff. Conference and Health EXPO live-online event will take place on November 4-5, 2021. This…

Non classé

18 October 2021

Da Volterra attending BIO-Europe® 27th Annual International Partnering Conference on October 25-28, 2021

Fulfilling its mission for the sector to connect the international life science community, the international BIO-Europe® 2021 gathering will once…

news

26 July 2021

Da Volterra Announces First Patient Randomized in Phase 3 Clinical Trial Evaluating the Gut Microbiome Protector DAV132 in Patients with Hematologic Malignancies

• World’s first phase 3 study of a microbiome protector, conducted as part of the European COMBACTE-NET program …